Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes

Date
2001
Author
Karsidag, K
Satman, I
Demirel, HO
Dinccag, N
Yilmaz, MT
Salman, S
Salman, F
Yilmaz, Y
Ozer, E
Sengul, A
Metadata
Show full item record
Abstract
Aim: To compare the effect of acarbose and gliclazide on clinical findings, biochemical parameters and safety in type 2 diabetic patients insufficiently controlled with medical nutrition therapy (MNT).
URI
http://hdl.handle.net/20.500.12627/72213
https://doi.org/10.1185/030079901750120231
Collections